Abstract:Aims Participants with cardiovascular diseases (CVD) often exhibit liver function abnormalities, hepatic fibrosis and cirrhosis. The extent of liver fibrosis is closely related to the prognosis of CVD. However, the association between the liver fibrosis‐8 (FIB‐8) index, a marker of liver fibrosis, and all‐cause mortality in CVD participants remains unclear. This study aims to investigate the relationship between the FIB‐8 index and all‐cause mortality among individuals with CVD. Materials and Methods A total of 1727 CVD American participants were enrolled from the National Health and Nutrition Examination Survey (NHANES) spanning from 1999 to 2018. Initially, we constructed weighted COX regression models and performed sensitivity analyses to examine the correlation between the FIB‐8 index and all‐cause mortality in CVD participants. Subsequently, we employed restricted cubic spline (RCS) to visualize their linear relationship. Finally, the stratified analyses and interaction tests of covariates were performed and presented in the forest plot. Results A total of 1727 participants were included in our study, with a mean age of 61.68 ± 0.47 years, with men accounting for 59.19%. After adjustment for relevant covariables, weighted COX regression models indicated that the hazard ratio (HR) and 95% confidence interval (95% CI) for the association between the FIB‐8 index and all‐cause mortality in CVD participants was 1.21 (1.12, 1.30). Sensitivity analysis was then conducted, revealing that the results remained stable. In fully adjusted model, individuals in quartiles 3 and 4 demonstrated significant statistical differences compared to the lowest FIB‐8 index quartile, with HR (95% CI) values of 1.88 (1.23, 2.87) and 2.17 (1.33, 3.53), respectively. Subsequently, RCS showed a linear relationship between the FIB‐8 index and all‐cause mortality among CVD participants. Finally, the interaction test revealed that no other covariables had significant interactions with the FIB‐8 index in this study. Conclusions A positive and linear correlation was observed between the FIB‐8 index and all‐cause mortality among CVD adult participants in NHANES from 1999 to 2018. Our findings indicated that the FIB‐8 index could serve as an excellent indicator for assessing all‐cause mortality within the CVD population. The lower the FIB‐8 index, the lower the all‐cause mortality among CVD participants.

Fibrosis-4 Index Predicts Mortality in HIV/HCV Co-Infected Patients Receiving Combination Antiretroviral Therapy in Rural China.

Importance Of Fibrosis 4 Index Score And Mode Of Anti-Fungal Treatment To The Outcome Of Cryptococcal Meningitis In Hepatitis B Virus-Infected Patients

Fibrosis-4 Score Is Associated with Mortality in Hemodialysis Patients with Chronic Viral Hepatitis: A Retrospective Study

Liver fibrosis after antiretroviral therapy in a longitudinal cohort of sexually infected HIV patients in eastern China.

Combination Antiretroviral Therapy is Associated with Reduction in Liver Fibrosis Scores in Patients with HIV and HBV Co-Infection.

End-stage Liver Disease: Prevalence, Risk Factors and Clinical Characteristics in a Cohort of HIV-HCV Coinfected Han Chinese.

Severe Liver Fibrosis and Association with Plasma Inflammatory Biomarkers among HIV/HCV Co-infected Patients in China :a Cross-Sectional Study

Profiling Circulating Inflammation and Microbial Translocation Biomarkers Associated with Advanced Liver Fibrosis in HIV/HCV Coinfected Persons

Impact of HIV-1 Infection on the Natural Progress of an Anti-HCV Positive Population in an Impoverished Village in China from 2009 to 2017.

Association between liver fibrosis scores and the risk of mortality among patients with coronary artery disease.

Risk factors of death in HIV/HCV co-infected patients with combined antiretroviral therapy

Association of liver fibrosis scores with all‐cause and cardiovascular mortality in patients with heart failure

More improvement than progression of liver fibrosis following antiretroviral therapy in a longitudinal cohort of HIV-infected patients with or without HBV and HCV co-infections.

Prevalence and Risk Factors of End-Stage Liver Disease in a Cohort of Human Immunodeficiency Virus and Hepatitis C Virus Co-Infected Patients Treated with Antiretroviral Therapy

Fibrosis Index Based on 4 Factors (FIB-4) Predicts Liver Cirrhosis and Hepatocellular Carcinoma in Chronic Hepatitis C Virus (HCV) Patients

Plasma Inflammatory Biomarkers Associated with Advanced Liver Fibrosis in HIV–HCV-Coinfected Individuals

The liver fibrosis‐8 index is a predictor for all‐cause mortality in cardiovascular disease patients: A cohort study

Annual Change in FIB-4, but Not in APRI, Was a Strong Predictor for Liver Disease Progression in Chinese Patients with Chronic Hepatitis C

FIB-4 index associated with mortality risk of patients with systemic lupus erythematosus: a large retrospective cohort study

Fibrosis‐4 Index as an Independent Predictor of Mortality and Liver‐Related Outcomes in NAFLD

Accuracy of FIB-4 and APRI Scores Compared to Transient Elastography for Liver Fibrosis in Patients with HIV and HBV Co-Infection.